MBD2 and cancer: In order to search for new drugs against Theileria parasites which might overcome emerging resistance to the Buparvaquone reference drug, we screened a library of 150 compounds (that includes chromatin modifying compounds, histone deacetylase and demethylase inhibitors) first developed as anti-cancer drugs and then found active as antimicrobial agents21–23.